Loading…
Krystal Biotech, Inc. is projected to rise to $502.29 by 2027, a +37% move from its current price of $366.85. KRYS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $358.89 | $367.02 | $375.32 | +0.05% |
| Aug 2 | $355.75 | $367.19 | $378.99 | +0.09% |
| Aug 3 | $353.39 | $367.35 | $381.87 | +0.14% |
| Aug 4 | $351.43 | $367.52 | $384.35 | +0.18% |
| Aug 5 | $349.74 | $367.69 | $386.56 | +0.23% |
| Aug 6 | $348.23 | $367.86 | $388.59 | +0.27% |
| Aug 7 | $346.87 | $368.03 | $390.48 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $346.87 | $368.03 | $390.48 | +0.32% |
| Week 2 | $339.55 | $369.21 | $401.46 | +0.64% |
| Week 3 | $334.29 | $370.39 | $410.39 | +0.96% |
| Week 4 | $330.08 | $371.58 | $418.29 | +1.29% |
| Week 5 | $326.54 | $372.77 | $425.54 | +1.61% |
| Week 6 | $323.47 | $373.96 | $432.34 | +1.94% |
| Week 7 | $320.76 | $375.16 | $438.79 | +2.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Krystal Biotech, Inc. is a commercial-stage biotechnology company that discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB).
Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Krystal Biotech, Inc. (KRYS) is currently priced at $350.24 with a market cap of $10.32B. It is ranked 911 by market capitalization and relative size among peers.
The near-term outlook reflects a price trajectory that starts from a 2026 average of $350.24 and progresses to higher long-run averages. By 2050, the forecast shows an average price of $5,584.02 with a maximum of $9,518.76, indicating substantial upside potential over the multi-year horizon. The predicted upside is complemented by a projected max in the hundreds to thousands range in later years, with an estimated return reaching 1,494.3% by 2050.
A major floor 33.1% below — a decisive break under it would weaken the trend.
The nearest floor, 10.7% below — buyers have tended to step in here.
The nearest ceiling, 3.1% above — a clean break opens room to run.
A major ceiling 11.3% above — clearing it would confirm fresh momentum.
Key KRYS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KRYS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $356.27 | Buy | $358.21 | Buy |
| MA 10 | $347.88 | Buy | $353.62 | Buy |
| MA 20 | $355.23 | Buy | $351.28 | Buy |
| MA 50 | $336.40 | Buy | $336.67 | Buy |
| MA 100 | $302.95 | Buy | $312.59 | Buy |
| MA 200 | $271.18 | Buy | $277.29 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.32 | Neutral |
| Stoch RSI (14) | 93.14 | Sell |
| CCI (20) | 56.84 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.31 | Buy |
| ROC (12) | 8.08 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | 4.31 | Buy |
| Ultimate (7,14,28) | 65.80 | Neutral |
| Momentum (10) | 25.06 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 369.57 | Sell |
| ADX (14) | 20.14 | Buy |
| ATR (14) | 7.51 | Info |
The 30-day technical picture is bullish, with the RSI14 at 50 indicating balanced momentum near the midpoint. The stock’s 50-day simple moving average sits at $326.25, while the 200-day moving average is $262.01, suggesting a positive longer-term trend.
Near-term support is at $293.21 and resistance at $378.15. The 30-day price range runs from a low of $303.74 to a high of $403.85, reflecting a solid trading band in the current month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $244.71 | $366.85 | $499.42 | 0% | Neutral | |
| $407.12 | $502.29 | $650.94 | +37% | Bullish | |
| $451.03 | $569.24 | $761.37 | +55% | Bullish | |
| $525.28 | $675.44 | $926.01 | +84% | Bullish | |
| $604.01 | $789.47 | $1,105.12 | +115% | Bullish | |
| $731.24 | $970.04 | $1,382.84 | +164% | Bullish | |
| $905.12 | $1,217.31 | $1,763.95 | +232% | Bullish | |
| $1,030.36 | $1,403.66 | $2,064.40 | +283% | Bullish | |
| $1,165.34 | $1,606.95 | $2,395.94 | +338% | Bullish | |
| $1,253.67 | $1,748.89 | $2,640.96 | +377% | Bullish | |
| $2,194.30 | $3,224.59 | $5,137.30 | +779% | Bullish | |
| $4,102.15 | $6,580.30 | $11,342.20 | +16.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $244.71 | $366.85 | $427.39 | +0.00% |
| August 2026 | $315.54 | $368.93 | $440.36 | +0.57% |
| September 2026 | $324.91 | $382.47 | $461.61 | +3.67% |
| October 2026 | $332.35 | $393.38 | $478.93 | +2.85% |
| November 2026 | $332.07 | $394.82 | $484.10 | +0.37% |
| December 2026 | $339.00 | $404.72 | $499.42 | +2.51% |
Click any year to see its month-by-month KRYS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The KRYS price prediction for 2026 points to an average of $366.85 (low $244.71, high $499.42) — a potential gain of 0% on today's $366.85. Price action looks broadly range-bound.
In 2027, KRYS is projected to trade between $407.12 and $650.94, averaging $502.29 — a potential gain of +37% from today's $366.85. That is up +37% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Krystal Biotech, Inc.'s 2028 outlook centres on $569.24, within a $451.03 to $761.37 range. That is up +13% on the projected 2027 average. That marks a +55% change versus current levels. Momentum favours further upside here.
By 2029, KRYS could reach as high as $926.01, with a base case around $675.44 and support toward $525.28 — roughly +84% from $366.85. Buyers look set to stay in control over this stretch.
Expect KRYS to range from $604.01 to $1,105.12 through 2030. The $789.47 average target implies a +115% move from current prices. That is up +17% on the projected 2029 average. Momentum favours further upside here.
The KRYS price prediction for 2031 points to an average of $970.04 (low $731.24, high $1,382.84) — a potential gain of +164% on today's $366.85. Buyers look set to stay in control over this stretch.
In 2032, KRYS is projected to trade between $905.12 and $1,763.95, averaging $1,217.31 — a potential gain of +232% from today's $366.85. That is up +25% on the projected 2031 average. Momentum favours further upside here.
Krystal Biotech, Inc.'s 2033 outlook centres on $1,403.66, within a $1,030.36 to $2,064.40 range. That is up +15% on the projected 2032 average. That marks a +283% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, KRYS could reach as high as $2,395.94, with a base case around $1,606.95 and support toward $1,165.34 — roughly +338% from $366.85. Momentum favours further upside here.
Expect KRYS to range from $1,253.67 to $2,640.96 through 2035. The $1,748.89 average target implies a +377% move from current prices. That is up +9% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The KRYS price prediction for 2040 points to an average of $3,224.59 (low $2,194.30, high $5,137.30) — a potential gain of +779% on today's $366.85. Momentum favours further upside here.
In 2050, KRYS is projected to trade between $4,102.15 and $11,342.20, averaging $6,580.30 — a potential gain of +16.9x from today's $366.85. That is up +104% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in KRYS today (≈ 2.72591 KRYS) could be worth
$17,937.3
+$16,937.3 (+1694%) by 2050 · US Dollar
Based on the average projected KRYS price of $6,580.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KRYSwould be worth at today's price.
$1,000 invested in KRYS on Jul 30, 2025 (≈ 6.526563 KRYS) would be worth
$2,394.27
+$1,394.27 (+139.4%) today · 2.39× · US Dollar
Based on a KRYS entry price of $153.22 vs. today's $366.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $327.5 | $1,120.15 | +12.0% |
| 1 month ago | $371.67 | $987.03 | -1.3% |
| 3 months ago | $266.04 | $1,378.93 | +37.9% |
| 6 months ago | $279.24 | $1,313.74 | +31.4% |
| 1 year ago | $153.22 | $2,394.27 | +139.4% |
| All time (5.0y) ago | $57.89 | $6,337.02 | +533.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KRYS forecast.
Our base-case forecast reaches $730.00 around 2030.
Implied market cap at $730.00: $21.52B
The multi-year forecast shows bullish sentiment across the horizon, with the 2026 average at $350.24 and an ongoing rise in annualized averages through 2050. Notably, the forecast projects 2027 average of $474.12 and 2030 average of $722.74, highlighting meaningful upside as milestones unfold. The 2040 average is $2,737.81 and the 2050 average reaches $5,584.02, with respective rois of 681.7% and 1,494.3%.
These figures imply strong longer-term appreciation, albeit as estimates subject to market conditions and other uncertainties.
Key year-by-year markers include 2027 avg $474.12, 2028 avg $524.69, 2029 avg $631.85, 2030 avg $722.74, 2040 avg $2,737.81, and 2050 avg $5,584.02. The forecast consistently signals bullish momentum beyond 2026, but the figures are estimates and not guarantees of future performance.
Tap a question to reveal the answer.
Avg $722.74, min $555.23, max $1,006.49, ROI 106.3%. The sentiment is BULLISH.
Forecasts show a neutral stance in 2026 and bullish sentiment from 2027 onward, with rising averages and ROIs—2027 Avg $474.12 (ROI 35.4%), 2030 Avg $722.74 (ROI 106.3%), 2040 Avg $2,737.81 (ROI 681.7%), and 2050 Avg $5,584.02 (ROI 1,494.3%). These are estimates, not guarantees.
Yes, the 2030 forecast max is $1,006.49, indicating a potential to exceed $1,000 in that year.
Current price: $350.24. Market cap: $10.32B.
Sentiment: BULLISH; RSI14: 50; SMA50: $326.25; SMA200: $262.01; 30-day range: $303.74 to $403.85; Support: $293.21; Resistance: $378.15.
Krystal Biotech, Inc. Community Discussion
0Share your Krystal Biotech, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.